📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
34%
📉 Score Deterioration
40%
• Score rose 17 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($60M, 12% of market cap)
• Active ATM program with $60M remaining capacity
🔄 Reverse Split
15%
• 52-week low $0.27 has breached $1
💹 Market Data
Market Cap$509.53M
Shares Outstanding186.64M
Float161.29M
Cash$155.52M
Debt$13.07M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 81.7% shares (2025Q4 vs prior)
86 institutional holders · 66.72M shares
#1
RA CAPITAL MANAGEMENT, L.P.
10.71M shares
#2
ADAR1 Capital Management, LLC
8.57M shares
#3
Affinity Asset Advisors, LLC
7.15M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest10.09M
Days to Cover4.6
% of Float6.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
424B3
ATM
Apr 27, 2026
EFFECT
EFFECT
Apr 24, 2026
S-3
SHELF
Apr 21, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for OVID
📊 OVID FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 OVID Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.